All results
1 results
-
Protocol TN-28
A multi-center, placebo-controlled, double blind, 2:1 randomized control clinical trial testing low-dose ATG vs. placebo in subjects with a 2 year 50% risk of…
- Ages
- 12 Years - 34 Years
- Sexes
- All